Imbalance in cytokine production by whole blood related to presence of cytopathogenic HIV-1 strains in HIV-1-infected patients

Infection

Volumn 26, Issue 2, 1998, Pages 109-112

  Benyoucef, S ^a   Lion, G ^b   Gerard Y ^c   Wattre P ^a   De Groote, D ^d   Hober, D ^a  

^a Service de Pathologie Professionnelle et Environnement   (France)

^b CENTRE HOSPITALIER DE VALENCIENNES   (France)

^c CENTRE HOSPITALIER DE TOURCOING   (France)

^d Medgenix   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

EID: 0031891815     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02767770     Document Type: Article

References (13)

1. Schuitemaker, H., Kootstra, N. A., Dercksen, M. W., De Guede, R. E. Y., Van Steenwijk, R. P., Lange, J. M. A., Schattenkerk, J. K. M. E., Miedema, F., Tersmette, M.: Biological phenotype of human immunodeficiency virus type-1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to cell-tropic populations. J. Virol. 66 (1992) 1354-1360.
2. Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., Fenyö, E. M.: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii (1986) 660-662.
3. Connor, R. I., Mohri, H., Cao, Y., Ho, D. D.: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyle decline and clinical progression in human immunodeficiency virus type 1-infected indivuduals. J. Virol. 67 (1993) 1772-1777.
4. Matsuyama, T., Kobayashi, N., Yamamoto, N.: Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5 (1991) 1405-1417.
5. Clerici, M., Hakim, F. T., Venzon, D. J., Blatt, S. P., Hendrix, C. W., Wynn, T. A., Shearer, G. M.: Changes in interleukin 2 and interleukin 4 production in asymptomatic, HIV-seropositive individuals. J. Clin. Invest. 91 (1993) 759-765.
6. Vigano, A., Balotta, C., Trabattoni, D., Salvaggio, A., Riva, C., Bricalli, D., Crupi, L., Colombo, M. C., Principl, N., Galli, M., Clerici, M.: Virologic and immunologic markers of disease progression in pediatric HIV infection. AIDS Res. Hum. Retroviruses 12 (1996) 1255-1262.
7. Clerici, M., Balotta, C., Salvaggio, A., Riva, C., Trabattoni, D., Papagno, L., Berlusconi, A., Rusconi, S. Villa, M. L., Moroni, M., Galli, M.: Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 88 (1996) 574-579.
8. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR (1992) 1-19.
9. Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchét, F., Dehart, I., Jadoul, M., Radoux, D., Franchimont, P.: Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163 (1993) 259-267.
10. Chameau, P., Alizon, M., Clavel, F.: A second origin of plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66 (1992) 2814-2820.
11. Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., Wattré, P.: A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40 (1996) 381-388.
12. Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Sonia, G.-I., Mizuno, D., Kobayashi, N.: Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5 (1989) 139-143.
13. Meyaard, L., Hovenkamp, E., Keet, I. P. M., Hooibrink, B., de Jong, I. H., Otto, S. A., Miedema, F.: Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J. Immunol. 157 (1996) 2712-2718.